Silver nanoparticle (AgNP) based approaches using plant materials have been accepted as biomedical applications. The current study aimed to test the antibacterial, antibiofilm, and anticancer activity of silver nanoparticles synthesized by seed extract of Nigella sativa (Ns) as stabilizing and reducing agents. Characterization was done through UV–visible spectroscopy, X-ray diffraction (XRD), Fourier transform infrared (FTIR) spectroscopy, scanning electronic microscopy (SEM), and transmission electronic microscopy (TEM) analyses. UV-Vis spectroscopy showed a specific silver plasmon peak at 400 nm and a quick color change was observed in the bio-reaction medium. Electron microscopic images of Ns-AgNPs identified as spherical in shape with varied size ranged between 8 and 80 nm and zeta potential analysis evidenced the particles stability and polydisperity. Antibiofilm activity of Ns-AgNPs was evident as at 12.5 µg/mL Ns-AgNps restricted the biofilm formation by 88.42% for Enterococcus faecalis, 84.92% for E. coli, 81.86% for Klebsiella pneumonia, 82.84% for Staphylococcus aureus, and 49.9% for Pseudomonas aeruginosa, respectively. Furthermore, biologically synthesized AgNPs showed the significant bacteriostatic and bactericidal activity. Even the lowest concentration of Ns-AgNps restricted the highest rate of inhibition against S. aureus (6.5 and 15 µg/mL) and E. faecalis (6.5 and 15 µg/mL). Antimicrobial activity of S. aureus and E. fecalis was more prominent than E. coli (15 and 30 µg/mL), K. pneumonia (15 and 30 µg/mL) and P. aeruginosa (30 and 60 µg/mL) respectively. Moreover, Ns-AgNPs revealed significant cytotoxic ability and substantially killed human breast cancer cell (HCC-712) viability. The results of current study advocate that Ns-AgNps may be considered as a potential option in biomedical applications, alternative therapy, designing anti-biofilm agents, treating multi drug resistance bacterial infection, and anti-cancer therapy.

Green nanotechnology is the evolution of cost-effective and environmentally friendly processes for the production of metal-based nanoparticles due to medicinal importance and economic value. The aim of the present study was to biosynthesize and characterize silver nanoparticles (AgNPs) using the seed extract of Ajwa dates (Aw). The anti-bacteriostatic activity of biosynthesized Aw–AgNPs against Gram-positive and Gram-negative bacterial strains was evaluated. The anti-biofilm activity was examined by the tissue culture plate method. Lastly, the anti-cancer potential of Aw–AgNPs was investigated against the human breast cancer cell line HCC712. UV–visible absorption spectra exhibited the plasmon resonance peak at 430 nm, with the solution undergoing rapid color changes that verified the existence of biosynthesized silver nanoparticles in the solution. TEM and SEM images illustrated that the Aw–AgNPs were spherical and between 15 and 80 nm in diameter. The reduction and stabilization of Aw–AgNPs was due to the functional groups present in the biomolecules of the Ajwa seeds, as identified by FTIR. The Aw–AgNPs exhibited significant anti-bacterial activity against all the tested bacterial strains. Moreover, the Aw–AgNPs efficiently hampered the biofilm formation of the bacterial strains and exhibited cytotoxicity at various concentrations. Overall, these findings suggest that biosynthesized Aw–AgNPs may be used as a potential therapeutic formulation against bacterial infections and breast cancer.